| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K04800985 |
| PharmacoGx | BRD-K04800985 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | LRP5L | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | IRX2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | CDC42BPG | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | ABCA9 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | TEAD2 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | GAGE12J | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | DHH | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ERG | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | PTGIR | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
